Evaluation of health perceptions and healthcare utilization among population-based female cancer survivors and cancer-free women.


Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 05 05 2021
accepted: 24 09 2021
pubmed: 7 10 2021
medline: 11 1 2022
entrez: 6 10 2021
Statut: ppublish

Résumé

Cancer survivors are more likely to report having a poor health status when compared to the general population. Few studies have focused on the impact of cancer on health status and healthcare utilization/access outcomes among women from medically underserved populations. 25,741 women with and without a history of cancer from the National Health and Nutrition Examination Survey from 1999 to 2016 contributed data. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression for associations between cancer status and perceived health and healthcare utilization/access outcomes stratified by race/ethnicity, poverty status, education, and comorbidities. 1,897 (7.0%) women had a history of cancer with breast cancer as the most common (n = 671, 35.7%). While most survivors were non-Hispanic white (69.4%), 13.9% were Hispanic, 12.0% were non-Hispanic Black, and 4.6% were additional racial/ethnic groups. Survivors were 1.32 times more likely to be hospitalized within the last year (95% CI 1.11-1.58) and 1.32 times more likely to see a mental health provider within the last year (95% CI 1.05-1.66) compared to cancer-free women. Race/ethnicity was a significant effect modifier in the association between being a survivor and seeing a mental health provider, with Hispanic survivors having the highest odds (aOR 3.44; 95% CI 2.06-5.74; p-interaction < 0.00). Our study identifies disparities in healthcare utilization among female cancer survivors, highlighting the importance of evaluating these associations among medically underserved populations. These findings can educate healthcare professionals working with these populations to inform gaps in survivorship care utilization/access.

Identifiants

pubmed: 34613541
doi: 10.1007/s10552-021-01498-y
pii: 10.1007/s10552-021-01498-y
pmc: PMC8738151
mid: NIHMS1765995
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-62

Subventions

Organisme : NIDDK NIH HHS
ID : T32DK062707
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006973
Pays : United States
Organisme : NCI NIH HHS
ID : T32CA009314
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK062707
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009314
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

J Oncol Pract. 2015 Mar;11(2):145-50
pubmed: 25515717
J Cancer Surviv. 2014 Sep;8(3):336-48
pubmed: 24532045
Oncology (Williston Park). 2018 Jan 15;32(1):32-8
pubmed: 29447419
Support Care Cancer. 2015 Nov;23(11):3201-9
pubmed: 25821145
J Clin Oncol. 2012 Apr 10;30(11):1215-20
pubmed: 22412133
CA Cancer J Clin. 2019 May;69(3):166-183
pubmed: 30786025
Breast Cancer Res. 2018 Oct 19;20(1):124
pubmed: 30340503
Fam Med Community Health. 2017 Jul;5(2):129-138
pubmed: 30956969
BMC Public Health. 2020 Jan 31;20(1):153
pubmed: 32005213
Clin J Oncol Nurs. 2011 Feb;15(1):E3-12
pubmed: 21278033
J Cancer Surviv. 2015 Dec;9(4):567-75
pubmed: 25676473
Psychooncology. 2015 Jan;24(1):80-8
pubmed: 24818821
Psychooncology. 2014 Jan;23(1):40-51
pubmed: 23983079
Support Care Cancer. 2021 May;29(5):2385-2394
pubmed: 32918610
Psychooncology. 2012 Sep;21(9):1016-25
pubmed: 21608075
J Cancer Surviv. 2018 Dec;12(6):775-785
pubmed: 30341560
J Med Person. 2013 Aug 1;11(2):
pubmed: 24349677
Medicine (Baltimore). 2017 Dec;96(50):e9125
pubmed: 29390313
Lancet Oncol. 2017 Jan;18(1):e11-e18
pubmed: 28049573
Cancer. 2004 Oct 15;101(8):1712-9
pubmed: 15386307
Lancet Oncol. 2017 Jan;18(1):e30-e38
pubmed: 28049575
Am J Prev Med. 2015 Dec;49(6 Suppl 5):S477-82
pubmed: 26590642
Oncologist. 2016 Jul;21(7):817-24
pubmed: 27245567
Support Care Cancer. 2020 Jan;28(1):211-220
pubmed: 31001695
J Clin Oncol. 2016 Feb 20;34(6):611-35
pubmed: 26644543
Lancet Oncol. 2013 Jul;14(8):721-32
pubmed: 23759376
Int J Environ Res Public Health. 2018 Aug 28;15(9):
pubmed: 30154349
Lancet Oncol. 2017 Jan;18(1):e39-e50
pubmed: 28049576
Virtual Mentor. 2007 Jan 01;9(1):48-51
pubmed: 23217671
J Natl Cancer Inst. 2015 Dec 11;108(5):
pubmed: 26657334
Am J Psychother. 2021 Mar 1;74(1):13-21
pubmed: 33028079
Med Clin North Am. 2017 Nov;101(6):1099-1113
pubmed: 28992857
Support Care Cancer. 2011 Dec;19(12):1921-9
pubmed: 21140173
Breast Cancer. 2015 Nov;22(6):648-56
pubmed: 26350490
J Med Internet Res. 2019 Apr 23;21(4):e10256
pubmed: 31012855
J Clin Oncol. 2014 May 20;32(15):1605-19
pubmed: 24733793
Am J Manag Care. 2018 Apr;24(4):188-195
pubmed: 29668209
J Prim Care Community Health. 2017 Jul;8(3):169-175
pubmed: 28606031
Am Psychol. 2015 Feb-Mar;70(2):159-74
pubmed: 25730722
Am Soc Clin Oncol Educ Book. 2016;35:231-9
pubmed: 27249703
J Cancer Surviv. 2015 Mar;9(1):50-8
pubmed: 25108481
J Cancer Metastasis Treat. 2019;5:
pubmed: 31236478
Acta Oncol. 2017 Apr;56(4):618-627
pubmed: 28084890
Am J Prev Med. 2015 Dec;49(6 Suppl 5):S489-97
pubmed: 26590644
BMC Health Serv Res. 2012 Sep 13;12:316
pubmed: 22973899
Int J Environ Res Public Health. 2020 Apr 16;17(8):
pubmed: 32316224
Int J Cancer. 2007 Aug 15;121(4):871-7
pubmed: 17417782
Nurs Res. 2012 May-Jun;61(3):231-7
pubmed: 22551998
Cancer. 2006 Jun 1;106(11):2482-8
pubmed: 16634097
Acta Oncol. 2004;43(6):536-44
pubmed: 15370610
Cancer Causes Control. 2016 Jan;27(1):115-24
pubmed: 26518195
J Psychosoc Oncol. 2017 Jul-Aug;35(4):424-437
pubmed: 28332946
BMC Cancer. 2020 Jan 28;20(1):2
pubmed: 31987032
Am J Med Sci. 2008 Apr;335(4):254-9
pubmed: 18461726
Support Care Cancer. 2021 Aug;29(8):4295-4302
pubmed: 33415363
Cancer. 2017 Mar 1;123(5):869-878
pubmed: 27859009
J Natl Cancer Inst. 2015 Dec 11;108(5):
pubmed: 26657336
Br J Sports Med. 2019 Apr;53(8):504-512
pubmed: 29162619
J Gen Intern Med. 2008 Feb;23(2):158-63
pubmed: 18060463
Surg Clin North Am. 2020 Jun;100(3):469-481
pubmed: 32402294
J Natl Cancer Inst. 2019 May 1;111(5):442-448
pubmed: 30726949
Support Care Cancer. 2013 Mar;21(3):901-6
pubmed: 23269420

Auteurs

Kate E Dibble (KE)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA. kdibble2@jhu.edu.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6133, Baltimore, MD, 21205, USA. kdibble2@jhu.edu.

Maneet Kaur (M)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.

Junrui Lyu (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.

Avonne E Connor (AE)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA.
Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH